InSight: Rémy Levastre of WSP looks at the future of healing people and place
Rémy Levastre, advisory director – healthcare, at engineering professional services firm WSP, asks: In the future, can hospitals heal both people and places?
Our world...
Mansfield Advisors see strong investor interest in ophthalmic product space
Deals in the surgical ophthalmic equipment and products market reached a record high of 31 deals in 2022, with PE backed transactions also attaining...
IIH interview: Verlinvest’s Julius Hugelshofer highlights the attractions of healthcare’s increasing consumerization
Verlinvest is an international evergreen investment company supported by the families behind one of the world's largest consumer groups, AB Invest. Established in 1995...
EU regulatory exclusivity changes: the increasing importance of patent monopolies for pharma
The regulatory data exclusivity and market protection regime in the European Union is changing. When implemented, the proposals will significantly alter the timelines of...
Investing through Europe’s regulatory overhaul
Luca Gambini, partner, and Claudio Todisco, associate, at Portolano Cavallo - an Italy-based full-service law firm operating in complex and evolving sectors and a...
The Pink Panther malpractice plot
Mike Griffiths, regional director of healthcare at Howden Insurance Brokers, talks through the implications of one of Asia’s most infamous malpractice suits last year
Gambling...
Australia: Royal Adelaide Hospital secures largest healthcare sustainability loan
Celsus, the commercial operator of Royal Adelaide Hospital (RAH), has secured the world’s largest sustainability loan in the healthcare sector, and the largest project...
InSight: Is pharma doing enough on sustainability?
Neeshe Williams, general counsel and head of ESG at Pharmanovia, considers the issue of sustainability in the pharmaceutical industry. Pharmanovia is a UK-based international...
InSight: Investment opportunities in the global animal feed market
The global animal feed market is estimated at US$500bn, including additives at US$41bn, and both are growing faster than the population at 4%.1 The...
MWE’s Peter Lu assesses implications of China opening its health industry to investors
A recent announcement signals a relaxation of restrictions on foreign investment in Chinese healthcare, yet Chinese healthcare remains heavily regulated. It will be crucial...
Advertisement
